Filters
The use of a smartwatch-based atrial fibrillation (AF) screening results in improved detection rates of new-onset AF relative to standard care in patients at increased risk of stroke, reports a study.
Gout does not contribute to an increased risk of overall dementia and may even be protective against Alzheimer's disease (AD) and cognitive impairment, according to the results of a systematic review and meta-analysis.
In Chinese hypertensive patients, lowering systolic blood pressure (BP) to a target of <120 mm Hg for 3 years appears to have no adverse effect on cognitive function, according to a study.
For individuals at high risk of cardiovascular disease (CVD), adherence to healthy dietary patterns confers stroke protection, as reported in a study.
Exposure to fine particulate matter PM2.5 may elevate the risk for Alzheimer’s disease (AD), mainly through direct pathways instead of mediation by common comorbidities, suggests a study.
Cumulative angiotensin II–stimulating (vs angiotensin II–inhibiting) antihypertensive exposure is associated with lower risk of certain dementia-related neuropathologies, a US study has found.
A cross-sectional analysis presented at ISC 2026 suggests that a decline in mobility is an earlier functional manifestation of covert cerebral small vessel disease (CSVD) than cognitive impairment.
A Mendelian randomization (MR) study shows an association between a high BMI and a higher risk of vascular-related dementia, which is partly mediated through high blood pressure (BP).
Diets such as the Dietary Approaches to Stop Hypertension (DASH) and those with lower hyperinsulinemia and inflammation potential have beneficial effects on cognitive health, as shown in a study.
A recent study provides evidence lending support to established recommendations for early glycaemic control in patients with type 2 diabetes to reduce their risk of developing dementia.